A novel injury site-natural antibody targeted complement inhibitor protects against lung transplant injury.
第一作者:
Changhai,Li
第一单位:
The Hepatic Surgery Centre at Tongji Hospital, Tongji Medical College, HUST, Wuhan, China.;Hubei Province for the Clinical Medicine Research Center of Hepatic Surgery, Key Laboratory of Organ Transplantation, Ministry of Education and Ministry of Public Health, Wuhan, China.;Department of Microbiology and Immunology, Medical University of South Carolina, Microbiology and Immunology, Charleston, South Carolina, USA.
作者:
医学主题词
动物(Animals);补体灭活剂(Complement Inactivating Agents);人类(Humans);免疫球蛋白M(Immunoglobulin M);肺损伤(Lung Injury);肺移植(Lung Transplantation);小鼠(Mice);再灌注损伤(Reperfusion Injury);移植物(Transplants)
DOI
10.1111/ajt.16404
PMID
33210808
发布时间
2024-04-02
基金项目
R03 HL135227/HL/NHLBI NIH HHS/United States
R01 DK102912/DK/NIDDK NIH HHS/United States
K23 HL116656/HL/NHLBI NIH HHS/United States
UL1 TR000062/TR/NCATS NIH HHS/United States
R01 HL140470/HL/NHLBI NIH HHS/United States
IK6 BX005235/BX/BLRD VA/United States
R56 AI119026/AI/NIAID NIH HHS/United States
T32 HL007260/HL/NHLBI NIH HHS/United States
R01 AR051749/AR/NIAMS NIH HHS/United States
U01 AI132894/AI/NIAID NIH HHS/United States
U01 AI170075/AI/NIAID NIH HHS/United States
- 浏览2
American journal of transplantation
2067-2078页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



